Please use this identifier to cite or link to this item: http://hdl.handle.net/10553/50097
DC FieldValueLanguage
dc.contributor.authorNaranjo, Antonioen_US
dc.contributor.authorCáceres, Lauraen_US
dc.contributor.authorHernández-Beriaín, José Ángelen_US
dc.contributor.authorFrancisco, Félixen_US
dc.contributor.authorOjeda, Soledaden_US
dc.contributor.authorTalaverano, Sigriden_US
dc.contributor.authorNóvoa-Medina, Javieren_US
dc.contributor.authorMartín, José Adánen_US
dc.contributor.authorDelgado, Esmeraldaen_US
dc.contributor.authorTrujillo, Elisaen_US
dc.contributor.authorÁlvarez, Fátimaen_US
dc.contributor.authorMagdalena, Lauraen_US
dc.contributor.authorRodríguez-Lozano, Carlosen_US
dc.date.accessioned2018-11-24T13:16:27Z-
dc.date.available2018-11-24T13:16:27Z-
dc.date.issued2016en_US
dc.identifier.issn1699-258Xen_US
dc.identifier.urihttp://hdl.handle.net/10553/50097-
dc.description.abstractObjective:To analyze compliance with t2t clinical practice guidelines.Methods:Cross-sectional observational study in consecutive patients with rheumatoid arthritis (RA) in 5 hospitals in the Canary Islands. Patients filled out activity scales, HAQ and answered the question of whether the doctor had explained the treatment target. The rheumatologist also collected: visits in the past year, use of activity indices and HAQ, DAS28 of current visit and date of the next visit. The percentage of compliance to indicators based on the t2t recommendations (R) 1, 3, 5-7 and 10 was analyzed.Results:A total of 343 patients were recruited, 77% female, mean age 57, RA duration of 10 years. Median visits in the last year were 3 and mean time between last and current visit was 5.6 months. A total of 93% of the patients were treated with DMARDs and 44% were in remission by DAS (R1). In the previous visit, documented joint count was present in 85%, a HAQ in 19%, patient VAS in 41%, and a DAS28 in 35% of the patients (R6). The next visit was scheduled at an average of 4.3 months (R5). In 64% of patients with DAS28> 3.2 a visit between one and 3 months was scheduled (R5). A total of 96% of patients said they had been informed of the treatment target (R10). Variability between centers existed but was moderate. The only factor determining the performance of a DAS28 in the last visit was the patient's center of origin.Conclusion:The Canary Island centers studied achieved high levels of remission and low activity in their patients. The performance of composite indices and follow-up frequency recommended by the t2t are met, although there is room for improvement.en_US
dc.languageengen_US
dc.relation.ispartofReumatologia Clinicaen_US
dc.sourceReumatologia Clinica[ISSN 1699-258X],v. 12, p. 34-38en_US
dc.subject32 Ciencias médicasen_US
dc.subject320509 Reumatologíaen_US
dc.subject.otherRemission Induction Cohorten_US
dc.subject.otherRecommendationsen_US
dc.subject.otherStrategyen_US
dc.titleAdjustment in the clinical practice of treat-to-target guidelines for rheumatoid arthritis: Results of the ToARCan studyen_US
dc.typeinfo:eu-repo/semantics/Articleen_US
dc.typeArticleen_US
dc.identifier.doi10.1016/j.reuma.2015.03.003en_US
dc.identifier.scopus84954388945-
dc.identifier.isi000399027300007-
dc.contributor.authorscopusid7003297397-
dc.contributor.authorscopusid56189466100-
dc.contributor.authorscopusid6603328312-
dc.contributor.authorscopusid6603342951-
dc.contributor.authorscopusid57198031414-
dc.contributor.authorscopusid8654250900-
dc.contributor.authorscopusid36469248100-
dc.contributor.authorscopusid36543104200-
dc.contributor.authorscopusid56582939700-
dc.contributor.authorscopusid54412193400-
dc.contributor.authorscopusid7003918641-
dc.contributor.authorscopusid56583492900-
dc.contributor.authorscopusid56584057000-
dc.contributor.authorscopusid6603136298-
dc.description.lastpage38en_US
dc.description.firstpage34en_US
dc.relation.volume12en_US
dc.investigacionCiencias de la Saluden_US
dc.type2Artículoen_US
dc.contributor.daisngid34966644-
dc.contributor.daisngid5636869-
dc.contributor.daisngid550893-
dc.contributor.daisngid1113798-
dc.contributor.daisngid343824-
dc.contributor.daisngid3734413-
dc.contributor.daisngid7192408-
dc.contributor.daisngid7105076-
dc.contributor.daisngid1345339-
dc.contributor.daisngid838281-
dc.contributor.daisngid27082302-
dc.contributor.daisngid6136907-
dc.contributor.daisngid1048977-
dc.description.numberofpages5en_US
dc.utils.revisionen_US
dc.contributor.wosstandardWOS:Naranjo, A-
dc.contributor.wosstandardWOS:Caceres, L-
dc.contributor.wosstandardWOS:Hernandez-Beriain, JA-
dc.contributor.wosstandardWOS:Francisco, F-
dc.contributor.wosstandardWOS:Ojeda, S-
dc.contributor.wosstandardWOS:Talaverano, S-
dc.contributor.wosstandardWOS:Novoa-Medina, J-
dc.contributor.wosstandardWOS:Martin, JA-
dc.contributor.wosstandardWOS:Delgado, E-
dc.contributor.wosstandardWOS:Trujillo, E-
dc.contributor.wosstandardWOS:Alvarez, F-
dc.contributor.wosstandardWOS:Magdalena, L-
dc.contributor.wosstandardWOS:Rodriguez-Lozano, C-
dc.date.coverdateEnero 2016en_US
dc.identifier.ulpgcen_US
dc.contributor.buulpgcBU-MEDen_US
dc.description.esciESCI-
item.fulltextSin texto completo-
item.grantfulltextnone-
crisitem.author.deptGIR IUIBS: Grupo de investigaciones infecciosas, nutricionales e inflamatorias en pacientes hospitalarios / Study Group on infectious, nutritional and inflammatory diseases in hospitalized patients-
crisitem.author.deptIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.deptDepartamento de Ciencias Médicas y Quirúrgicas-
crisitem.author.deptDepartamento de Ciencias Médicas y Quirúrgicas-
crisitem.author.orcid0000-0002-2013-6664-
crisitem.author.parentorgIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.fullNameNaranjo Hernández, Antonio-
crisitem.author.fullNameHernández Beriain, José Ángel-
Appears in Collections:Artículos
Show simple item record

SCOPUSTM   
Citations

1
checked on May 26, 2024

WEB OF SCIENCETM
Citations

1
checked on May 26, 2024

Page view(s)

25
checked on Oct 29, 2022

Google ScholarTM

Check

Altmetric


Share



Export metadata



Items in accedaCRIS are protected by copyright, with all rights reserved, unless otherwise indicated.